Aurora Spine Announces the Resignation of Board Director James Snow
Aurora Spine (OTCQB: ASAPF) announced that James Snow, a board member since 2012, has resigned from the Board of Directors to become the company's Regulatory Affairs and Quality Assurance Manager. Snow, who brings over 20 years of medical device experience in regulatory affairs and quality, will focus on ensuring compliance requirements are met and exceeded.
The transition marks Snow's shift from a strategic to an operational role, where he will leverage his industry expertise to drive quality and compliance across Aurora's expanding innovative product portfolio. The company, which specializes in designing and manufacturing innovative medical devices for spinal surgery outcomes, views this internal movement as strengthening their operational capabilities.
Aurora Spine (OTCQB: ASAPF) ha annunciato che James Snow, membro del consiglio dal 2012, si è dimesso dal Consiglio di Amministrazione per assumere il ruolo di Responsabile Affari Regolatori e Garanzia Qualità dell'azienda. Snow, con oltre 20 anni di esperienza nel settore dei dispositivi medici in ambito regolatorio e qualità, si concentrerà sull'assicurare il rispetto e il superamento dei requisiti di conformità.
Questa transizione segna il passaggio di Snow da un ruolo strategico a uno operativo, dove metterà a frutto la sua esperienza nel settore per migliorare la qualità e la conformità nell'ampio e innovativo portafoglio prodotti di Aurora. L'azienda, specializzata nella progettazione e produzione di dispositivi medici innovativi per la chirurgia spinale, considera questo spostamento interno un rafforzamento delle proprie capacità operative.
Aurora Spine (OTCQB: ASAPF) anunció que James Snow, miembro de la junta desde 2012, ha renunciado al Consejo de Administración para asumir el cargo de Gerente de Asuntos Regulatorios y Aseguramiento de Calidad de la empresa. Snow, con más de 20 años de experiencia en dispositivos médicos en asuntos regulatorios y calidad, se enfocará en garantizar que se cumplan y superen los requisitos de conformidad.
Esta transición marca el cambio de Snow de un rol estratégico a uno operativo, donde aprovechará su experiencia en la industria para impulsar la calidad y el cumplimiento en la creciente cartera de productos innovadores de Aurora. La empresa, especializada en el diseño y fabricación de dispositivos médicos innovadores para resultados en cirugía de columna, considera este movimiento interno como un fortalecimiento de sus capacidades operativas.
Aurora Spine (OTCQB: ASAPF)는 2012년부터 이사회 멤버였던 James Snow가 이사회에서 사임하고 회사의 규제 업무 및 품질 보증 관리자로 임명되었다고 발표했습니다. 의료기기 분야에서 20년 이상의 규제 및 품질 경험을 가진 Snow는 규정 준수 요구 사항을 충족하고 이를 초과 달성하는 데 주력할 것입니다.
이번 전환은 Snow가 전략적 역할에서 운영적 역할로 이동하는 것을 의미하며, 그는 업계 전문성을 활용해 Aurora의 확장 중인 혁신적 제품 포트폴리오 전반에 걸쳐 품질과 규정 준수를 강화할 예정입니다. 척추 수술 결과를 위한 혁신적인 의료기기 설계 및 제조를 전문으로 하는 이 회사는 이번 내부 이동을 운영 역량 강화로 보고 있습니다.
Aurora Spine (OTCQB : ASAPF) a annoncé que James Snow, membre du conseil d'administration depuis 2012, a démissionné du conseil pour devenir Responsable des Affaires Réglementaires et de l'Assurance Qualité de l'entreprise. Snow, qui possède plus de 20 ans d'expérience dans les dispositifs médicaux en affaires réglementaires et qualité, se concentrera sur le respect et le dépassement des exigences de conformité.
Cette transition marque le passage de Snow d'un rôle stratégique à un rôle opérationnel, où il mettra à profit son expertise sectorielle pour renforcer la qualité et la conformité au sein du portefeuille de produits innovants en pleine expansion d'Aurora. L'entreprise, spécialisée dans la conception et la fabrication de dispositifs médicaux innovants pour la chirurgie de la colonne vertébrale, considère ce mouvement interne comme un renforcement de ses capacités opérationnelles.
Aurora Spine (OTCQB: ASAPF) gab bekannt, dass James Snow, seit 2012 Vorstandsmitglied, aus dem Vorstand ausgeschieden ist, um die Position des Leiters für Regulatory Affairs und Qualitätsmanagement im Unternehmen zu übernehmen. Snow, der über 20 Jahre Erfahrung im Bereich medizinischer Geräte in den Bereichen Regulatory Affairs und Qualität verfügt, wird sich darauf konzentrieren, die Einhaltung der Vorschriften sicherzustellen und zu übertreffen.
Dieser Wechsel markiert Snows Übergang von einer strategischen zu einer operativen Rolle, in der er seine Branchenerfahrung nutzen wird, um Qualität und Compliance im wachsenden innovativen Produktportfolio von Aurora voranzutreiben. Das Unternehmen, das sich auf die Entwicklung und Herstellung innovativer medizinischer Geräte für Wirbelsäulenchirurgie spezialisiert hat, sieht diese interne Veränderung als Stärkung seiner operativen Fähigkeiten.
- Internal promotion maintains continuity and institutional knowledge
- Addition of 20+ years regulatory affairs expertise to operational management
- Strengthened quality and compliance oversight for product portfolio
- Loss of long-standing board member since 2012
- Need to fill board vacancy
CARLSBAD, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that James Snow, a board member for Aurora Spine since its inception in 2012, has resigned from the Aurora Spine Board of Directors to take on the role of Regulatory Affairs and Quality Assurance Manager for the Company. Mr. Snow will use his 20+ years of medical device experience in regulatory affairs and quality to ensure Aurora Spine meets and exceeds all compliance requirements it has in this area.
“We are very happy to announce that Jim Snow, a long-standing member of our Board of Directors, will be taking a more active role within the Company,” said Trent Northcutt, President and CEO of Aurora Spine. “Jim has been an invaluable contributor to our mission and vision, and we are excited to now benefit from his deep industry expertise and leadership on a full-time basis. His transition from Board Member to a key operational role underscores his belief in Aurora’s future, and we couldn’t be more confident in the impact he’ll make in driving quality and compliance across our expanding innovative product portfolio.”
David Rosenkrantz, Chairman of the Board at Aurora Spine, added, “Jim’s dedication to Aurora has always gone beyond boardroom discussions. Jim’s decision to join the team in an operational capacity demonstrates his commitment and passion for our company and the incredible potential he sees in our technologies.”
About Aurora Spine
Aurora Spine is focused on bringing new solutions to the spinal implant and pain care markets through a series of screwless, innovative, minimally invasive, regenerative spinal implant technologies. Additional information can be accessed at www.aurora-spine.com or www.aurorapaincare.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.
Contact:
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004
Chad Clouse
Chief Financial Officer
(760) 424-2004
www.aurora-spine.com
FAQ
Why did James Snow resign from Aurora Spine's (ASAPF) Board of Directors in April 2025?
How long was James Snow on Aurora Spine's (ASAPF) Board before his resignation?
What will be James Snow's new role at Aurora Spine (ASAPF)?
What experience does James Snow bring to his new position at Aurora Spine (ASAPF)?
